Back to List View Graph View

Interleukin 10

Interleukin 10 (IL-10) is an anti-inflammatory cytokine encoded by the IL10 gene.

Where the papers sit

9 papers from the last 6 months study interleukin 10 directly · updated from PubMed 16 Nov 2026

Study type 0 clinical trials · 1 observational · 3 human data · 5 preclinical

Themes 3 themes

  • Localized Immune Modulation

    Localized IL-10 delivery is moving toward cell- and organ-targeted immunomodulation rather than systemic cytokine exposure. Regulatory B cells and engineered cytokine-producing cells suppress myeloid-driven autoimmunity and foreign-body inflammation. Pancreas-directed lipid nanoparticles extend this strategy to IL-10 mRNA for acute pancreatitis. Durability, biodistribution, and translation from rodents to primates remain open.

    3 papers · 33.3%

  • Phytochemical Mechanism Discovery

    Network pharmacology and molecular docking are being used to connect phytochemicals with therapeutic targets in wound healing and hepatocellular carcinoma. Ginsenoside-Rd and compounds from Zanthoxylum nitidum are linked to pathways involving fibroblast proliferation, TNF signaling, and cancer-related regulation. Experimental verification is beginning to test computationally nominated mechanisms. Disease-specific efficacy and causal target validation remain limited.

    2 papers · 22.2%

  • Others — Cytokine Immune Profiling

    Cytokine measurements and immune-associated gene signatures are being used to characterize disease activity, tumor immunophenotype, and prognosis. IL-6, TNF-α, interferon gamma, CTLA-4, and related markers recur across neurological disease and cancer studies. Engineered IL-10-producing MSCs represent a therapeutic branch rather than a shared biomarker approach. The cluster lacks a unified clinical direction, linking immune assessment with exploratory intervention.

    4 papers · 44.4%

Papers

The 9 papers from the last 6 months that study interleukin 10 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Localized Immune Modulation (3)
  1. Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity · 6 Oct 2026 PMID 42838057
  2. Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate. Science advances · 5 Aug 2026 PMID 42555743
  3. Pancreas-specific lipid nanoparticle-mediated interleukin-10 mRNA delivery ameliorates acute pancreatitis. Journal of materials chemistry. B · 3 Aug 2026 PMID 42544423
Phytochemical Mechanism Discovery (2)
  1. Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
  2. Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics. Artificial cells, nanomedicine, and biotechnology · 24 Jul 2026 PMID 42498300
Others — Cytokine Immune Profiling (4)
  1. Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human cell · 2 Sept 2026 PMID 42684559
  2. Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease. ACS applied bio materials · 10 Aug 2026 PMID 42575082
  3. Vasoactive intestinal peptide associated 8-gene signature with prognostic and immune associations in melanoma. Medicine · 30 May 2026 PMID 42216340
  4. Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension. Brain research · 29 May 2026 PMID 42214536

By study type

Observational studies and case reports (1)
  1. Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension. Brain research · 29 May 2026 PMID 42214536
Human data, design not indexed (3)
  1. Cytokines and chemokines in plasma as markers reflecting immunophenotype of head and neck squamous cell carcinoma. Human cell · 2 Sept 2026 PMID 42684559
  2. Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics. Artificial cells, nanomedicine, and biotechnology · 24 Jul 2026 PMID 42498300
  3. Vasoactive intestinal peptide associated 8-gene signature with prognostic and immune associations in melanoma. Medicine · 30 May 2026 PMID 42216340
Preclinical: animal, cell and lab studies (5)
  1. Induced regulatory B cells stably expressing interleukin-10 reverse central nervous system autoimmunity by targeting myeloid cells. Immunity · 6 Oct 2026 PMID 42838057
  2. Exploring the mechanism of Panax notoginseng injection in the treatment of skin wound based on network pharmacology and experimental verification. Journal of molecular histology · 4 Sept 2026 PMID 42696214
  3. Engineering IL-10-Overexpressing MSCs via a Non-Viral PEG-PEI Nanoplatform for Potent Therapy of Inflammatory Bowel Disease. ACS applied bio materials · 10 Aug 2026 PMID 42575082
  4. Localized immunomodulation with cytokine-producing cells to mitigate foreign body responses in rodents and a nonhuman primate. Science advances · 5 Aug 2026 PMID 42555743
  5. Pancreas-specific lipid nanoparticle-mediated interleukin-10 mRNA delivery ameliorates acute pancreatitis. Journal of materials chemistry. B · 3 Aug 2026 PMID 42544423